| [1] |
Bruni D, Angell HK, Galon J. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy[J]. Nat Rev Cancer, 2020, 20(11): 662-680.
|
| [2] |
Castaño Z, San Juan BP, Spiegel A, et al. IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization[J]. Nat Cell Biol, 2018, 20(9): 1084-1097.
|
| [3] |
Monteran L, Ershaid N, Sabah I, et al. Bone metastasis is associated with acquisition of mesenchymal phenotype and immune suppression in a model of spontaneous breast cancer metastasis[J]. Sci Rep, 2020, 10(1): 13838.
|
| [4] |
Jiang X, Wang J, Deng X, et al. The role of microenvironment in tumor angiogenesis[J]. J Exp Clin Cancer Res，2020, 39(1)：204.
|
| [5] |
Ding TT, Yan F, Cao S, et al. Regulatory B cell: new member of immunosuppressive cell club[J]. Human Immunol, 2015, 76(9): 615-621.
|
| [6] |
Nagarsheth N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy[J]. Nat Rev Immunol, 2017, 17(9): 559-572.
|
| [7] |
Katsuta E, Rashid OM, Takabe K. Clinical relevance of tumor microenvironment: immune cells, vessels, and mouse models[J]. Human Cell，2020，33(4): 930-937.
|
| [8] |
Zhang Y, Gallastegui N, Rosenblatt JD. Regulatory B cells in anti-tumor immunity[J]．Int Immunol，2015，27(10)：521-530.
|
| [9] |
Jayasingam SD, Citartan M, Thang TH, et al. Evaluating the polarization of tumor-associated macrophages into M1 and M2 phenotypes in human cancer tissue: technicalities and challenges in routine clinical practice[J]. Front Oncol, 2020, 9：1512.
|
| [10] |
Dai X, Lu L, Deng S, et al. USP7 targeting modulates anti-tumor immune response by reprogramming tumor-associated macrophages in lung cancer[J]. Theranostics, 2020, 10(20): 9332-9347.
|
| [11] |
Kitamura T, Qian BZ, Soong D, et al. CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages[J]. J Exp Med, 2015, 212(7): 1043-1059.
|
| [12] |
Zhang M, Liu ZZ, Aoshima K, et al. CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression[J]. Sci Transl Med，2022, 14(630)：eabf5473.
|
| [13] |
Ruiz-Torres SJ, Bourn JR, Benight NM, et al. Macrophage-mediated RON signaling supports breast cancer growth and progression through modulation of IL-35[J]. Oncogene, 2022, 41(3): 321-333.
|
| [14] |
Lu WC, Xie H, Yuan C, et al. Genomic landscape of the immune microenvironments of brain metastases in breast cancer[J]. J Transl Med, 2020, 18(1)：327.
|
| [15] |
Xiao Y, Cong M, Li J, et al. Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation[J]．Cancer Cell, 2021，39(3)：423-437.
|
| [16] |
Yang L, Liu Q, Zhang X, et al. DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25[J]. Nature, 2020, 583(7814)：133-138.
|
| [17] |
Wang Z, Yang C, Li L, et al. Tumor-derived HMGB1 induces CD62L(dim) neutrophil polarization and promotes lung metastasis in triple-negative breast cancer[J]. Oncogenesis, 2020, 9(9): 82.
|
| [18] |
Hagerling C, Gonzalez H, Salari K, et al. Immune effector monocyte-neutrophil cooperation induced by the primary tumor prevents metastatic progression of breast cancer[J]. Proc Natl Acad Sci U S A, 2019, 116(43): 21 704-21 714.
|
| [19] |
Wu L, Saxena S, Goel P, et al. Breast cancer cell-neutrophil interactions enhance neutrophil survival and pro-tumorigenic activities[J]. Cancers (Basel), 2020, 12(10): 2884
|
| [20] |
Ding L, Li Q, Chakrabarti J, et al. MiR130b from Schlafen4+ MDSCs stimulates epithelial proliferation and correlates with preneoplastic changes prior to gastric cancer[J]．Gut，2020，69(10)：1750-1761.
|
| [21] |
Kumar V, Patel S, Tcyganov E, et al. The nature of myeloid-derived suppressor cells in the tumor microenvironment[J]. Trends Immunol, 2016，37(3): 208-220.
|
| [22] |
Danilin S, Merkel AR, Johnson JR, et al. Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction[J]．Oncoimmunology，2012，1(9)：1484-1494.
|
| [23] |
Deng Z, Rong Y, Teng Y, et al. Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis[J]. Oncogene, 2017, 36(5): 639-651.
|
| [24] |
Yu B, Luo F, Sun B, et al. KAT6A acetylation of SMAD3 regulates myeloid-derived suppressor cell recruitment, metastasis, and immunotherapy in triple-negative breast cancer[J]. Adv Sci (Weinh), 2021, 8(20): e2100014.
|
| [25] |
Bottos A, Gotthardt D, Gill JW, et al. Decreased NK-cell tumour immunosurveillance consequent to JAK inhibition enhances metastasis in breast cancer models[J]．Nat Commun，2016，7：12 258.
|
| [26] |
Brownlie D, Doughty-Shenton D, Yh Soong D, et al. Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth factor β[J]. J Immunother Cancer, 2021, 9(1): e001740.
|
| [27] |
Knab VM, Gotthardt D, Klein K, et al. Triple-negative breast cancer cells rely on kinase-independent functions of CDK8 to evade NK-cell-mediated tumor surveillance[J]. Cell Death Dis, 2021, 12(11): 991.
|
| [28] |
Sawant A, Hensel JA, Chanda D, et al. Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells[J]. J Immunol，2012，189(9)：4258-4265.
|
| [29] |
Gong Z, Li Q, Shi J, et al. Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment[J]. Immunity, 2022, 55(8): 1483-1500.
|
| [30] |
Ghoneim HE, Zamora AE, Thomas PG, et al. Cell-intrinsic barriers of T cell-based immunotherapy[J]. Trends Mol Med, 2016, 22(12): 1000-1011.
|
| [31] |
Liu S, Song A, Zhou X, et al.ceRNA network development and tumour-infiltrating immune cell analysis of metastatic breast cancer to bone[J]. J Bone Oncol, 2020, 24: 100 304.
|
| [32] |
Wang P, Xue L, Wang L, et al. Long noncoding RNA DLX6-AS1 promotes migration and invasion of breast cancer cells by upregulating FUS[J]. Panminerva Med, 2020 Jan 20. doi: 10.23736/S0031-0808.19.03773-X. Online ahead of print.
|
| [33] |
Mansurov A, Ishihara J, Hosseinchi P, et al. Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours[J]. Nat Biomed Eng，2020，4(5): 531-543.
|
| [34] |
Gao W, Wen H, Liang L, et al. IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer[J]. Theranostics, 2021, 11(6): 2564-2580.
|
| [35] |
Zhang Y, Gallastegui N, Rosenblatt JD. Regulatory B cells in anti-tumor immunity[J]. Int Immunol, 2015, 27(10): 521-530.
|
| [36] |
Vafaizadeh V, Buechel D, Rubinstein N, et al. The interactions of Bcl9/Bcl9L with β-catenin and pygopus promote breast cancer growth, invasion, and metastasis[J]. Oncogene，2021，40(43)：6195-6209.
|
| [37] |
Hosonaga M, Saya H, Arima Y. Molecular and cellular mechanisms underlying brain metastasis of breast cancer[J]. Cancer Metastasis Rev, 2020, 39(3): 711-720.
|
| [38] |
Moradpoor R, Gharebaghian A, Shahi F, et al. Identification and validation of stage-associated PBMC biomarkers in breast cancer using MS-based proteomics[J]. Front Oncol, 2020, 10: 1101
|